We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.
Researching areas of unmet medical need
Other specialty areas
We continue to focus on research and development for other disease areas of significant need, always with an improved quality of life for patients in mind.
Women's health
We are dedicated to researching, developing and providing additional therapies for the gynecologic care of women. Our drive to innovate and expand the medical treatment available is focused in two key areas of women’s health: contraceptives that increase the options available to help meet individual care preferences, and oral medications to manage the acute menstrual health conditions of endometriosis and uterine fibroids.
Cystic fibrosis
Cystic fibrosis (CF) is a rare, life-threatening, genetic disease that affects between 70,000 and 100,000 patients worldwide. In the US and UK, average life expectancy is 35 to 40 years old. In countries such as El Salvador, India and Bulgaria, life expectancy drops to below 15. There currently is no cure for CF. We are currently evaluating investigational compounds in early clinical phases for a triple combination therapy.
Diabetic nephropathy
Diabetic nephropathy, or diabetic kidney disease, is a common complication of diabetes and the leading cause of chronic kidney disease in the developing world. We are currently conducting a clinical study to assess the effects of an investigational drug on progression of kidney disease in patients with stage 2 to 4 CKD and type 2 diabetes.
